| (±)13(14)-EpDPA |
(±)13(14)-EpDPA |
895127-64-7 |
| 9ALPHA, 11ALPHA-AZOPROSTA-5Z,13E-DIEN-1-OIC ACID |
9ALPHA, 11ALPHA-AZOPROSTA-5Z,13E-DIEN-1-OIC ACID |
77331-77-2 |
| 7-(Methylthio)-2-[(2,2-diphenylacetyl)amino]benzo[1,2-d:4,3-d′]bisthiazole |
7-(Methylthio)-2-[(2,2-diphenylacetyl)amino]benzo[1,2-d:4,3-d′]bisthiazole |
397290-30-1 |
| 5-POHSA-d14 |
5-POHSA-d14 |
2749982-66-7 |
| SM-164 |
SM 164 |
957135-43-2 |
| 3X FLAG PEPTIDE |
3X FLAG PEPTIDE |
402750-12-3 |
| VASICINONE |
鸭嘴花碱酮 |
486-64-6 |
| (S)-6-[(3,5-Dimethyl-1H-pyrazol-4-yl)methyl]-5-[(4-hydroxyisoxazolidin-2-yl)carbonyl]-1-isobutyl-3-methylthieno[2,3-d]pyrimidine-2,4(1H,3H)-dione |
(S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-D]嘧啶-2,4(1H,3H)-二酮 |
496791-37-8 |
| R-(-)-2-(4-ISOBUTYLPHENYL)PROPIONYL METHANSULPHONAMIDE, LYSINE SALT |
REPERTAXIN L-赖氨酸盐 |
266359-93-7 |
| 1-OXAZOLO[4,5-B]PYRIDIN-2-YL-OCTADEC-9Z-EN-1-ONE |
1-OXAZOLO[4,5-B]PYRIDIN-2-YL-OCTADEC-9Z-EN-1-ONE |
288862-58-8 |
| 1,4-DIACETOXY-2,3-DICYANOBENZENE |
1,4-二乙酰基-2,3-二氰苯 |
83619-73-2 |
| PHGDH-inactive |
PHGDH-inactive |
1914971-16-6 |
| K145 (hydrochloride) |
3-(2-氨基乙基)-5-[3-(4-丁氧基苯基)亚丙基]-2,4-噻唑烷二酮盐酸盐 |
1449240-68-9 |
| Pep2m, myristoylated |
Pep2m, myristoylated |
1423381-07-0 |
| [4-[3′-(Hydroxymethyl)[1,1′-biphenyl]-4-yl]-1H-1,2,3-triazol-1-yl](2-phenyl-1-piperidinyl)-methanone |
KT182 |
1402612-62-7 |
| MK2-IN-1 (hydrochloride) |
1314118-94-9 |
1314118-94-9 |
| TENIDAP |
替尼达普 |
120210-48-2 |
| 4,5,6,7-Tetrahydro-N-[3-methoxy-4-(4-methyl-1H-imidazol-1-yl)phenyl]-4-phenyl-2-benzothiazolamine |
4,5,6,7-四氢-N-[3-甲氧基-4-(4-甲基-1H-咪唑-1-基)苯基]-4-苯基-2-苯并噻唑胺 |
1172637-87-4 |
| 3-Deoxy-D-glycero-D-galacto-2-nonulosonic acid |
尤罗索尼克酸 |
112543-66-5 |
| Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid |
Tetratriaconta-16(Z),19(Z),22(Z),25(Z),28(Z),31(Z)-hexaenoic Acid |
105528-06-1 |
